HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation
Authors
Keywords
HPIP/PBXIP1, PI3K/AKT pathway, Ovarian cancer, Epithelial-mesenchymal transition (EMT), Cell migration
Journal
CELLULAR ONCOLOGY
Volume 40, Issue 2, Pages 133-144
Publisher
Springer Nature
Online
2016-12-30
DOI
10.1007/s13402-016-0308-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells
- (2016) V. N. R. Gajulapalli et al. BIOCHEMICAL JOURNAL
- HPIP promotes non-small cell lung cancer cell proliferation, migration and invasion through regulation of the Sonic hedgehog signaling pathway
- (2016) Jia Pan et al. BIOMEDICINE & PHARMACOTHERAPY
- Upregulation of ABCG2 via the PI3K-Akt pathway contributes to acidic microenvironment-induced cisplatin resistance in A549 and LTEP-a-2 lung cancer cells
- (2016) CHUN FANG HU et al. ONCOLOGY REPORTS
- HPIP Silencing Prevents Epithelial-Mesenchymal Transition Induced by TGF-β1 in Human Ovarian Cancer Cells
- (2016) Guo-ying Zhang et al. ONCOLOGY RESEARCH
- Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells
- (2016) Justyna Mikuła-Pietrasik et al. CELLULAR ONCOLOGY
- HPIP promotes thyroid cancer cell growth, migration and EMT through activating PI3K/AKT signaling pathway
- (2015) Shun-chang Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Hematopoietic pre-B cell leukemia transcription factor interacting protein is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, migration, and invasion
- (2015) Yingying Feng et al. CANCER SCIENCE
- IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3′-diindolylmethane in ovarian cancer cells
- (2015) Minghua Zou et al. CELLULAR ONCOLOGY
- Metformin and epithelial ovarian cancer therapeutics
- (2015) Seema Patel et al. CELLULAR ONCOLOGY
- KDM1 is a novel therapeutic target for the treatment of gliomas
- (2015) Gangadhara R Sareddy et al. Oncotarget
- HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion
- (2015) Yingying Feng et al. Scientific Reports
- MDM2 restrains estrogen-mediated AKT activation by promoting TBK1-dependent HPIP degradation
- (2014) K Shostak et al. CELL DEATH AND DIFFERENTIATION
- Follicle-Stimulating Hormone Induced Epithelial-Mesenchymal Transition of Epithelial Ovarian Cancer Cells Through Follicle-Stimulating Hormone Receptor PI3K/Akt-Snail Signaling Pathway
- (2014) Yongbin Yang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Potential role of hematopoietic pre-B-cell leukemia transcription factor-interacting protein in oral carcinogenesis
- (2014) Seiji Okada et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Pre-B-cell leukemia homeobox interacting protein 1 is overexpressed in astrocytoma and promotes tumor cell growth and migration
- (2014) Dannis G. van Vuurden et al. NEURO-ONCOLOGY
- Hematopoietic PBX-interacting protein (HPIP) is over expressed in breast infiltrative ductal carcinoma and regulates cell adhesion and migration through modulation of focal adhesion dynamics
- (2014) S Bugide et al. ONCOGENE
- Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors
- (2013) Karen E. Sheppard et al. EUROPEAN JOURNAL OF CANCER
- Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis
- (2013) Xiaojie Xu et al. JOURNAL OF CLINICAL INVESTIGATION
- Platinum-Sensitive Recurrence in Ovarian Cancer: The Role of Tumor Microenvironment
- (2013) Jeremy Chien et al. Frontiers in Oncology
- Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
- (2012) Roel G.W. Verhaak et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- Genomic Complexity and AKT Dependence in Serous Ovarian Cancer
- (2011) Aphrothiti J. Hanrahan et al. Cancer Discovery
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay
- (2009) Veronika Auner et al. BMC CANCER
- Epithelial–mesenchymal transition in ovarian cancer
- (2009) Daniele Vergara et al. CANCER LETTERS
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Ovarian Cancer
- (2008) Kathleen R. Cho et al. Annual Review of Pathology-Mechanisms of Disease
- A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer
- (2008) T. Bonome et al. CANCER RESEARCH
- Establishment of an ovarian metastasis model and possible involvement of E-cadherin down-regulation in the metastasis
- (2008) Yoshiko Kuwabara et al. CANCER SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started